Anything around these levels looks like a great entry price given the potential upside.
Though I did think the same thing 12 months ago, and given the data and progress, naturally paying 1/3 a year later looks just as good, if not better.
Unless they poo the bed, we have a good amount of positive momentum ahead of us to get her moving north.
Keen for MPS data, some news around TGA/FDA, and then hopefully a regional deal or two by mid year.
Should have us sitting pretty and hopefully some shareholders on their way back to break even.
PAR. SP, page-493
-
- There are more pages in this discussion • 760 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |